XNCR Q2 2023 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$890M

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$46M+50.9% YoY

Gross Profit

-$15M-31.9% margin

Operating Income

-$26M-57.1% margin

Net Income

-$22M-48.2% margin

EPS (Diluted)

$-0.37

QoQ Revenue Growth

+140.1%

Cash Flow

Operating Cash Flow

-$38M

Free Cash Flow

-$43M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$778M

Total Liabilities

$99M

Stockholders' Equity

$679M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$46M	$30M	+50.9%
Gross Profit	-$15M	-$17M	+14.0%
Operating Income	-$26M	-$28M	+7.2%
Net Income	-$22M	-$34M	+35.4%

Revenue Segments

Research collaboration

$22M49%

Royalty

$13M29%

Milestone

$10M22%